ChoA Pharmaceutical Co., LTD. Statistics

Total Valuation

ChoA Pharmaceutical Co., LTD. has a market cap or net worth of KRW 31.38 billion. The enterprise value is 47.35 billion.

Market Cap	31.38B
Enterprise Value	47.35B

Important Dates

The next estimated earnings date is Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	n/a

Share Statistics

ChoA Pharmaceutical Co., LTD. has 30.98 million shares outstanding. The number of shares has decreased by -0.44% in one year.

Current Share Class	n/a
Shares Outstanding	30.98M
Shares Change (YoY)	-0.44%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	20.00%
Owned by Institutions (%)	0.21%
Float	24.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.51
PB Ratio	0.89
P/TBV Ratio	0.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.62
EV / Sales	0.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.62

Financial Position

The company has a current ratio of 1.29, with a Debt / Equity ratio of 0.76.

Current Ratio	1.29
Quick Ratio	0.82
Debt / Equity	0.76
Debt / EBITDA	n/a
Debt / FCF	-4.51
Interest Coverage	-10.73

Financial Efficiency

Return on equity (ROE) is -33.84% and return on invested capital (ROIC) is -11.48%.

Return on Equity (ROE)	-33.84%
Return on Assets (ROA)	-9.28%
Return on Capital (ROIC)	-11.48%
Revenue Per Employee	245.84M
Profits Per Employee	-52.29M
Employee Count	250
Asset Turnover	0.81
Inventory Turnover	3.37

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.25% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-52.25%
50-Day Moving Average	1,102.96
200-Day Moving Average	1,444.82
Relative Strength Index (RSI)	54.85
Average Volume (20 Days)	301,080

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ChoA Pharmaceutical Co., LTD. had revenue of KRW 61.46 billion and -13.07 billion in losses. Loss per share was -422.06.

Revenue	61.46B
Gross Profit	21.10B
Operating Income	-11.29B
Pretax Income	-13.52B
Net Income	-13.07B
EBITDA	-8.81B
EBIT	-11.29B
Loss Per Share	-422.06

Full Income Statement

Balance Sheet

The company has 6.17 billion in cash and 24.78 billion in debt, giving a net cash position of -18.60 billion or -600.51 per share.

Cash & Cash Equivalents	6.17B
Total Debt	24.78B
Net Cash	-18.60B
Net Cash Per Share	-600.51
Equity (Book Value)	32.66B
Book Value Per Share	1,139.32
Working Capital	9.21B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.78 billion and capital expenditures -706.94 million, giving a free cash flow of -5.49 billion.

Operating Cash Flow	-4.78B
Capital Expenditures	-706.94M
Free Cash Flow	-5.49B
FCF Per Share	-177.23

Full Cash Flow Statement

Margins

Gross margin is 34.33%, with operating and profit margins of -18.36% and -21.27%.

Gross Margin	34.33%
Operating Margin	-18.36%
Pretax Margin	-22.00%
Profit Margin	-21.27%
EBITDA Margin	-14.33%
EBIT Margin	-18.36%
FCF Margin	n/a

Dividends & Yields

ChoA Pharmaceutical Co., LTD. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.44%
Shareholder Yield	0.44%
Earnings Yield	-41.66%
FCF Yield	-17.50%

Stock Splits

The last stock split was on April 21, 2003. It was a forward split with a ratio of 10.

Last Split Date	Apr 21, 2003
Split Type	Forward
Split Ratio	10

Scores

ChoA Pharmaceutical Co., LTD. has an Altman Z-Score of 0.45. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.45
Piotroski F-Score	n/a